Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture

Annals of Allergy, Asthma and Immunology

Volumn 90, Issue 1, 2003, Pages 23-27

  Daikh, Brian E ^a,c   Ryan, Charlotte K ^a   Schwartz, Robert H ^a,b  

^a STRONG MEMORIAL HOSPITAL   (United States)

^b Allergy Asthma Immunology of Rochester   (United States)

^c Rheumatology Associate   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LACTALBUMIN; BETA LACTOGLOBULIN; CASEIN; CETIRIZINE; CROMOGLYCATE DISODIUM; CYPROHEPTADINE; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PEPTIDOLEUKOTRIENE; PREDNISONE; RANITIDINE; STEROID; ACETIC ACID DERIVATIVE; QUINOLINE DERIVATIVE;

ADULT; ARTICLE; BLOOD CELL COUNT; CASE REPORT; CLINICAL FEATURE; DENSITOMETRY; DIET RESTRICTION; DIET THERAPY; DISEASE SEVERITY; DRUG EFFECT; DRUG INDUCED DISEASE; DUODENOSCOPY; EGG; EOSINOPHIL; EOSINOPHILIA; EOSINOPHILIC GASTROENTERITIS; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS DILATATION; ESOPHAGUS STRICTURE; GASTROSCOPY; HISTOPATHOLOGY; HUMAN; LONG TERM CARE; LUNG LAVAGE; MALE; MILK; OSTEOPENIA; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST; SYMPTOM; TISSUE; TREATMENT OUTCOME; WHEAT; BLOOD; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; ESOPHAGUS STENOSIS; GASTROENTERITIS; LEUKOCYTE COUNT;

ACETATES; ADULT; EOSINOPHILIA; EOSINOPHILS; ESOPHAGEAL STENOSIS; GASTROENTERITIS; HUMANS; LEUKOCYTE COUNT; LEUKOTRIENE ANTAGONISTS; MALE; QUINOLINES; TREATMENT OUTCOME;

EID: 0037270690     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63609-5     Document Type: Article

References (20)

1. Lee M, Hodges WG, Huggins TL, Lee EL. Eosinophilic gastroenteritis. South Med J 1996;89:189-194.
2. Kaijser R. Zur Kenntnis der Allergischen Affektioner desima Verdanungskanal von Standpunkt desima Chirurgen aus. Arch Klin Chir 1937;188:36-64.
3. Jaffe JS, James SP, Mullins GE, et al. Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and γ-interferon (γ-INF) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis. J Clin Immunol 1994;14:299-309.
4. Kelly KJ, Lazenby AJ, Rowe PC, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995;109:1503-1512.
5. Rothenburg ME. Mechanisms of disease: eosinophilia. N Engl J Med 1998;338:1592-1600.
6. Melamed I, Feanny SJ, Sherman PM, Roifman CM. Benefit of ketotifen in patients with eosinophilic gastroenteritis. Am J Med 1991;90:310-314.
7. Liacouras CA, Wenner WJ, Brown K, Ruchelli E. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 1998;26: 380-385.
8. Faubion WA Jr, Perrault J, Burgart LJ, et al. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 1998;27:90-93.
9. Neustrom MR, Friesen C. Treatment of eosinophilic gastroenteritis with montelukast. J Allergy Clin Immunol 1999;104:506.
10. Shirai T, Hashimoto D, Suzuki K, et al. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate. J Allergy Clin Immunol 2001;107:924-925.
11. Reiss TF, Chervinsky P, Dockhorn RJ, et al. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med 1998;158:1213-1220.
12. Zhang J, Chervinsky P, Edwards T, et al. Montelukast, a cys LT1 receptor antagonist, decreases peripheral blood eosinophils and improves signs and symptoms of asthma over a 3 month period. J Allergy Clin Immunol 1997;99:S268.
13. Ramsey C, Li D, Wang D. Bronchial biopsy specimen variability: requirement for large sample size and repeated measurements to improve reliability. Am J Respir Crit Care Med 1999;159:A655.
14. Kita H, Adolphson CR, Gleich GJ. Biology of eosinophils. In: Middleton E Jr, Reed CF, Ellis EF, et al, editors. Allergy, Principles and Practice. St. Louis: Mosby, 1998:242-260.
15. 4 effects on human eosinophil and neutrophil motility in vitro. J Leukoc Biol 1994;55:183-191.
16. Desreumaux P, Bloget F, Seguy D, et al. Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology 1996;110: 768-774.
17. Bischoff SC, Mayer J, Nguyen QT, et al. Immunohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Am J Gastroenterol 1999;94:3521-3529.
18. Mishra A, Hogan SP, Lee JJ, et al. Fundamental signals that regulate eosinophil homing to the gastrointestinal tract. J Clin Invest 1999;103:1719-1727.
19. Fuller R, Johnson M, Bye A. Fluticasone propionate-an update on preclinical and clinical experience. Respir Med 1995; 89(Suppl):3-18.
20. Lee A, Robertson T, Smith J, et al. Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals. Am J Respir Crit Care Med. 2000;161: 1881-1886.